Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Gliomas
NCT00039364Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Mar 2002
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of imatinib in glioma, sponsored by European Organisation for Research and Treatment of Cancer. Started Mar 2002; status: completed.
02
Drugs
03
Conditions
glioma
Beyond the preview
Go deeper on NCT00039364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00039364.